Last reviewed · How we verify

NCT04378634: EPIME

Epigenetics of Post-exertional Malaise in Patients With ME/CFS

Completed NA Last updated 7 November 2023
What this trial tests

NA trial testing Exercise in Fatigue Syndrome, Chronic in 105 participants. Completed in 30 April 2023.

Timeline
1 April 2021
Primary endpoint
30 April 2023
30 April 2023

Quick facts

Lead sponsorVrije Universiteit Brussel
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment105
Start date1 April 2021
Primary completion30 April 2023
Estimated completion30 April 2023
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Vrije Universiteit Brussel — full company profile →

Who can join

Adults 18 to 70, female only, with Fatigue Syndrome, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exploring epigenetic mechanisms of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is crucial to understand the mechanisms underlying its pathophysiology. Three potential candidates have been selected (BDNF, COMT, and HDAC genes). DNA methylation in the promoter regions of those genes will be explored. The investigators designed a randomised controlled trial and will enrol 70 patients with ME/CFS and 35 age-, sex-, and BMI-matched healthy controls. Both groups will be randomised in 2 groups and receive either one session of aerobic exercise or a validated test designed to trigger mental stress and mental fatigue. The primary aim is to assess genetic and epigenetic mechanisms of BDNF, COMT and HDAC genes in response to exercise and the stress task.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Fatigue Syndrome, Chronic

Currently open trials in the same condition.

Other Vrije Universiteit Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04378634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing